CI Investments Inc
VERV

CI Investments Inc’s Verve Therapeutics VERV Stock Holding History

CI Investments Inc’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,433
Closed -$72K – 1317
2024
Q1 		$72K Buy
5,433
+5
+0.1% +$66 ﹤0.01% 952
2023
Q4 		$76K Buy
5,428
+1,672
+45% +$20.7K ﹤0.01% 904
2023
Q3 		$50K Sell
3,756
-112
-3% -$1.8K ﹤0.01% 968
2023
Q2 		$73K Buy
3,868
+1,608
+71% +$26.8K ﹤0.01% 866
2023
Q1 		$33K Sell
2,260
-29
-1% -$568 ﹤0.01% 993
2022
Q4 		$44K Buy
+2,289
New +$60.6K ﹤0.01% 963

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CI Investments Inc's VERV Position: Q2 2024 in Review

CI Investments Inc sold out of Verve Therapeutics (VERV) in Q2 2024, closing a stake of 5,433 shares — an estimated $72K sold.

CI Investments Inc first reported a position in VERV in Q4 2022 and held it in 6 quarters. The position peaked at $76K in Q4 2023. 166 funds tracked by Wall St. Rank hold VERV as of Q2 2024.

  • CI Investments Inc reported no remaining Verve Therapeutics position as of Q2 2024 after selling out during the quarter.
  • CI Investments Inc sold 5,433 Verve Therapeutics shares in Q2 2024, an estimated $72K.
  • CI Investments Inc first reported a position in Verve Therapeutics in Q4 2022 and held it in 6 quarters.
  • CI Investments Inc's Verve Therapeutics position peaked at $76K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2024.

Based on CI Investments Inc's 13F filing for Q2 2024, filed 12 Aug 2024.